Immunome, Inc. ( IMNM) - Stock Earnings
IMNM Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
IMNM Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -69.9 million USD | — USD |
| 2026Q1 | -53.8 million USD | — USD |
| 2026Q2 | -73.1 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
IMNM Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -106.8 million USD | 14.0 million USD |
| 2024 | -293.0 million USD | 9.0 million USD |
| 2025 | -212.4 million USD | 6.9 million USD |
| 2026 Est. | — | — |
IMNM
Price: $17.27
52 week price:
Earnings Per Share: -2.65 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 8759
Market Capitalization: 1.8 billion